Ovarian stimulation is a procedure that encourages multiple follicles to produce several mature eggs in a single cycle. This is achieved through the administration of various medications containing hormones.
PGT-A is an embryo selection technique offered at Ingenes to increase the probability of reproductive success by selecting chromosomally normal embryos. By performing this test, the chances of your baby developing conditions such as Down syndrome, Patau syndrome, Turner syndrome, among others, are minimized.
PGT-M, or Preimplantation Genetic Testing for monogenic disorders, is a technique applied to identify specific (heritable) genetic alterations that could affect your baby's health. Various heritable genetic alterations can be classified into three groups: autosomal dominant, autosomal recessive, and numerical alterations.
Our sex selection is based on the analysis of genes located on the sex chromosomes (X and Y). The presence or absence of these genes allows our experts in Molecular Biology to determine the sex of your embryos with 98% effectiveness. This procedure is carried out in the In Vitro Fertilization (IVF) Laboratory.
The Implantation Score (SI) enables us to calculate and predict the implantation potential of embryos, achieving an efficiency of up to 85%, much higher than values achieved using traditional embryo selection systems. When the Implantation Score is performed alongside Preimplantation Genetic Testing for Aneuploidies (PGT-A), this predictive efficiency increases to 92%.